Tetsuya Fujimori

Direttore/Membro del Consiglio presso Cenegenics Japan KK

55 anni

Health Technology

Consumer Services

Posizioni attive di Tetsuya Fujimori

Società	Posizione	Inizio	Fine
Cenegenics Japan KK Cenegenics Japan KK Medical SpecialtiesHealth Technology Cenegenics Japan KK engages in the advanced medical support business using genes, cells, and tissues. The company was founded on March 23, 2020 and is headquartered in Tokyo, Japan.	Direttore/Membro del Consiglio	01/03/2020	-

Società	Posizione	Inizio	Fine
TELLA, INC.	Direttore/Membro del Consiglio	25/03/2020	-
TELLA, INC.	Independent Dir/Board Member	25/03/2020	-

Osaka City University

Undergraduate Degree

Distribuzione geografica

Giappone

Posizioni

Director/Board Member	2
Independent Dir/Board Member	1
Undergraduate Degree	1

Settori

Health Technology	3
Consumer Services	2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Aziende private	2
tella, Inc. tella, Inc. BiotechnologyHealth Technology tella, Inc. engages in research and development of dendritic cell (DC) vaccine therapy. It operates through the following segments: Cell Medicine, Medical Support, and Pharmaceuticals. The Cell Medicine segment provides cancer treatment technology and know-hows centered on dendritic cell vaccine therapy. The Medical Support segment manages contact research organization (CRO) business and offers genetic testing services. The Pharmaceuticals segment deals with the development of dendritic cell vaccine as a cancer treatment. The company was founded by Yuichiro Yazaki on June 24, 2004 and is headquartered in Tokyo, Japan.	Health Technology
Cenegenics Japan KK Cenegenics Japan KK Medical SpecialtiesHealth Technology Cenegenics Japan KK engages in the advanced medical support business using genes, cells, and tissues. The company was founded on March 23, 2020 and is headquartered in Tokyo, Japan.	Health Technology

Aziende private

Health Technology